Posted on January 20, 20261/20/26
Navigating A New Era: Reflections on Canada’s Enhanced CDA-AMC Reimbursement Review Process
Posted on August 25, 20258/25/25
Evaluation of HTA Frameworks for In Vivo Diagnostics: Assessing Methodological Gaps and Implications for Market Access
Posted on April 11, 20254/11/25
Unlocking Pharma Success: Mike Ryan’s Pre-Conference Talk at Reuters Pharma 2025
Posted on June 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on June 24, 20246/24/24
Market Access and the Inflation Reduction Act
Posted on May 30, 20245/30/24
Optimizing Patient-Centered Care: Strategies for Improving Health Outcomes
Posted on May 23, 20245/23/24
Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
Posted on September 29, 20239/29/23
APACMed Digital Health Reimbursement Policy Forum
Posted on July 18, 20237/18/23